TY - JOUR
T1 - Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors
T2 - A systematic review and meta-analysis
AU - Patel, Hiten D.
AU - Pierorazio, Phillip M.
AU - Johnson, Michael H.
AU - Sharma, Ritu
AU - Iyoha, Emmanuel
AU - Allaf, Mohamad E.
AU - Bass, Eric B.
AU - Sozio, Stephen M.
N1 - Funding Information:
We thank Allen Zhang and Emily Little for their assistance in data abstraction. We also thank the Key Informants, Technical Expert Panel, Peer Reviewers, Dr. Steven Campbell, and the Agency for Healthcare Research and Quality (AHRQ) Task Order Officer Dr. Aysegul Gozu for their feedback and input on the evidence report from which this article was derived. This project was funded under contract HHSA290201200007I from the AHRQ, US Department of Health and Human Services. The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the AHRQ or the US Department of Health and Human Services.
Publisher Copyright:
© 2017 by the American Society of Nephrology.
PY - 2017/7/7
Y1 - 2017/7/7
N2 - Background and objectives Management strategies for localized renal masses suspicious for renal cell carcinoma include radical nephrectomy, partial nephrectomy, thermal ablation, and active surveillance. Given favorable survival outcomes across strategies, renal preservation is often of paramount concern. To inform clinical decision making, we performed a systematic review and meta-analysis of studies comparing renal functional outcomes for radical nephrectomy, partial nephrectomy, thermal ablation, and active surveillance. Design, settings, participants, & measurements We searched MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from January 1, 1997 to May 1, 2015 to identify comparative studies reporting renal functional outcomes. Meta-analyses were performed for change in eGFR, incidence of CKD, and AKI. Results We found 58 articles reporting on relevant renal functional outcomes. Meta-analyses showed that final eGFR fell 10.5 ml/min per 1.73 m2 lower for radical nephrectomy compared with partial nephrectomy and indicated higher risk of CKD stage 3 or worse (relative risk, 2.56; 95% confidence interval, 1.97 to 3.32) and ESRD for radical nephrectomy compared with partial nephrectomy. Overall risk of AKI was similar for radical nephrectomy and partial nephrectomy, but studies suggested higher risk for radical nephrectomy among T1a tumors (relative risk, 1.37; 95% confidence interval, 1.13 to 1.66). In general, similar findings of worse renal function for radical nephrectomy compared with thermal ablation and active surveillance were observed. No differences in renal functional outcomes were observed for partial nephrectomy versus thermal ablation. The overall rate of ESRD was low among all management strategies (0.4%–2.8%). Conclusions Renal functional implications varied across management strategies for localized renal masses, with worse postoperative renal function for patients undergoing radical nephrectomy compared with other strategies and similar outcomes for partial nephrectomy and thermal ablation. Further attention is needed to quantify the changes in renal function associated with active surveillance and nephron-sparing approaches for patients with preexisting CKD.
AB - Background and objectives Management strategies for localized renal masses suspicious for renal cell carcinoma include radical nephrectomy, partial nephrectomy, thermal ablation, and active surveillance. Given favorable survival outcomes across strategies, renal preservation is often of paramount concern. To inform clinical decision making, we performed a systematic review and meta-analysis of studies comparing renal functional outcomes for radical nephrectomy, partial nephrectomy, thermal ablation, and active surveillance. Design, settings, participants, & measurements We searched MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from January 1, 1997 to May 1, 2015 to identify comparative studies reporting renal functional outcomes. Meta-analyses were performed for change in eGFR, incidence of CKD, and AKI. Results We found 58 articles reporting on relevant renal functional outcomes. Meta-analyses showed that final eGFR fell 10.5 ml/min per 1.73 m2 lower for radical nephrectomy compared with partial nephrectomy and indicated higher risk of CKD stage 3 or worse (relative risk, 2.56; 95% confidence interval, 1.97 to 3.32) and ESRD for radical nephrectomy compared with partial nephrectomy. Overall risk of AKI was similar for radical nephrectomy and partial nephrectomy, but studies suggested higher risk for radical nephrectomy among T1a tumors (relative risk, 1.37; 95% confidence interval, 1.13 to 1.66). In general, similar findings of worse renal function for radical nephrectomy compared with thermal ablation and active surveillance were observed. No differences in renal functional outcomes were observed for partial nephrectomy versus thermal ablation. The overall rate of ESRD was low among all management strategies (0.4%–2.8%). Conclusions Renal functional implications varied across management strategies for localized renal masses, with worse postoperative renal function for patients undergoing radical nephrectomy compared with other strategies and similar outcomes for partial nephrectomy and thermal ablation. Further attention is needed to quantify the changes in renal function associated with active surveillance and nephron-sparing approaches for patients with preexisting CKD.
KW - Acute kidney injury
KW - Acute kidney injury
KW - Attention
KW - Carcinoma, renal cell
KW - Chronic kidney disease
KW - Clinical decision-making
KW - Confidence intervals
KW - Glomerular filtration rate
KW - Humans
KW - Incidence
KW - Kidney
KW - Kidney failure, chronic
KW - Kidney neoplasms
KW - MEDLINE
KW - Nephrectomy
KW - Nephrons
KW - Outcome studies
KW - Renal insufficiency, chronic
KW - Risk
UR - http://www.scopus.com/inward/record.url?scp=85021869128&partnerID=8YFLogxK
U2 - 10.2215/CJN.11941116
DO - 10.2215/CJN.11941116
M3 - Review article
C2 - 28483780
AN - SCOPUS:85021869128
SN - 1555-9041
VL - 12
SP - 1057
EP - 1069
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 7
ER -